insights_auto
Why is 0QF up 12,85%?
Dive Deeperchevron_right
0QF:FRA
Moderna Inc
197,54 €
arrow_upward
+12,85%(+22,50) 1D
9 հոկ, 22:00:00 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 0QF...
Open
174,60 €
High
200,00 €
Low
174,48 €
Mkt. cap
89,83 մլրդ
Avg. vol.
1,54 հզր
Volume
3,36 հզր
52-wk high
200,00 €
52-wk low
19,26 €
No. of employees
5 հզր
Open
174,60 €
High
200,00 €
Low
174,48 €
Mkt. cap
89,83 մլրդ
Avg. vol.
1,54 հզր
Volume
3,36 հզր
52-wk high
200,00 €
52-wk low
19,26 €
No. of employees
5 հզր
News stories
From web sources and news partners
MarketBeat
·
12 ժամ առաջ
11,652 Shares of Moderna, Inc. $MRNA Acquired by Gallagher Capital Advisors LLC
The Globe and Mail
·
1 օր առաջ
This Stock Is Up More than 560% This Year, but It Could Drop by 38%, According to Wall Street
Yahoo Finance
·
1 օր առաջ
Moderna stock hits 4-year high on planned national cancer vaccine effort
Benzinga
·
1 օր առաջ
Moderna Stock Hits New 52-Week High: What's Happening?
Profile
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In May 2026, Time ranked Moderna first in their list of the World's Most Impactful Companies. Wikipedia
About Moderna Inc